Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Quimi Daphne
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Amicus Therapeutics, Inc.
Amylyx Pharmaceuticals, Inc.
Century Therapeutics, Inc.
Amicus Therapeutics, Inc.
Chief Financial Officer
Avg. Two Year Performance
17%
Avg. Purchase Return
8%
Compound
10%
Avg. Sale Return
5%
Compound
Holdings:
398.53K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
